bioRASI

The Translational

Clinical Development CRO

Strong ICH-GCP foundation

 

Innovative application of fundamental scientific, regulatory and clinical knowledge.

 

Powerful capabilities in evaluation, compilation, and representation for IND (or equivalent) enablement.

 

Unique access and optimal utilization of opinion leaders, PI’s, clinics, special subject populations, regulatory venues, and other trial resources.

 

Potent ability to create novel medical solutions and skilfully enhance Sponsor IP foundation for major business impact.

 

 Strengths and Capabilities:

 

bioRASI has become a leader in clinical endpoint and clinical equivalence studies. We are arguably the world’s leading CRO in dermal programs, including transdermals. 

 

Our global infrastructure, including that in North America and Eastern Europe, provides an unrivaled access to PIs and special subject populations that allows for efficient and effective conduct of the trial.

Welcome

bioRASI is a Full Service Global CRO headquartered in Hollywood, Florida and with offices throughout North America and the rest of the world.  bioRASI collaborates with the leading biotech and pharmaceutical companies to achieve unparalleled scientific, clinical and business results. 

 

 

bioRASI is particularly strong in clinical equivalence studies where it has leveraged its unique global access to strong PIs and special patient populations to optimize clinical programs.  And, utilizing bioRASI’s Phase I clinics and bioanalytical laboratories, bioRASI has a rich history of successfully bringing candidates through CE and BE/BA studies.